Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

GLP-1 receptor agonists, best known by their brand names such as Ozempic (semaglutide) and Victoza (liraglutide), mimic a hormone that tells the body to release insulin. These drugs can help further ...

Too much of anything can be bad, and the consequence of too much of drugs is something we are all familiar with. Not all of us have tried these drugs, but cinema has shown us the most graphic and ...

The global drug trade exhibits striking regional differences, with varying drug preferences across different parts of the world. However, a common thread unites these regions: The pervasive rise ...

Eventually, this can lead to the need for insulin medication. You can effectively manage earlier phases like prediabetes with a balanced diet, exercise, and careful monitoring of blood sugars.

Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug, but only if specifically prescribed for a ...

which sells a once-weekly insulin product called insulin icodec in Europe, Canada, and other countries. In July, however, the U.S. Food and Drug Administration (FDA) rejected the company's application ...

told ABC News she often sees patients struggling to pay for their medications. One of Abhyankar's patients with diabetes couldn't afford his monthly dose of insulin, so "he would ration out his ...